Product Images Lyrica

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Lyrica NDC 68258-7980 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

NDC 68258-7980-09 - NDC 68258 7980 09 PFIZER

NDC 68258-7980-09 - NDC 68258 7980 09      PFIZER

The text describes medication information for bulk source data of LYRICA 75 mg capsules manufactured by Pfizer Pharmaceuticals LLC in Vega Baja, PR. Each capsule contains 75mg of PREGABALIN and may cause drowsiness. The medication should be taken orally every few hours, avoiding alcohol consumption. The capsules are dispensed with medication guide and stored in a tight/light-resistant container. They are sold in 90 capsules with NDC numbers 68258-7980-09 and 68268-7980-09. The medication may be habit-forming and is only for the patient for whom it was prescribed. The text also contains a caution regarding the transfer of the drug to anyone other than the patient. There is information regarding the RX and lot numbers, and expiration date. The medication should be kept out of children's reach and stored at 77°F. The text also includes the address for Pfizer Pharmaceuticals LLC in Santa Ana, CA 92704.*

Figure - lyrica 01

Figure - lyrica 01

Chemical Structure - lyrica 02

Chemical Structure - lyrica 02

Figure 1 - lyrica 03

Figure 1 - lyrica 03

This is a data table that shows the percentage of patients who have improved in their pain from baseline. However, due to the errors, it is difficult to understand the information presented in the table.*

Figure 2 - lyrica 04

Figure 2 - lyrica 04

Figure 3 - lyrica 05

Figure 3 - lyrica 05

Figure 4 - lyrica 06

Figure 4 - lyrica 06

Figure 5 - lyrica 07

Figure 5 - lyrica 07

This text is not readable due to errors.*

Figure 6 - lyrica 08

Figure 6 - lyrica 08

Figure 7 - lyrica 09

Figure 7 - lyrica 09

Figure 8 - lyrica 10

Figure 8 - lyrica 10

Figure 9 - lyrica 11

Figure 9 - lyrica 11

Figure 10 - lyrica 12

Figure 10 - lyrica 12

The text provided is displaying a graph or chart that shows the percentage of subjects improved over the course of 12 weeks. The numbers at the bottom appear to be the value ranges, and the "Percent Improved" text suggests that this is a graph showing improvement percentages. However, it is difficult to interpret the data accurately due to inconsistent spacing and unclear formatting. Therefore, it is not possible to provide a complete and accurate description.*

Figure 11 - lyrica 13

Figure 11 - lyrica 13

This is a statistical report presenting the percentage of subjects improved, with values ranging from 0 to 100. There are also two columns identified as "Pregabalin" and "Placebo", which may refer to different treatments or conditions. No further information or context is provided.*

Logo - lyrica 14

Logo - lyrica 14

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.